Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole

International Journal of Antimicrobial Agents

Volumn 35, Issue 3, 2010, Pages 311-312

  Lu, Ching Lan ^a   Liu, Chia Ying ^b   Liao, Chun Hsing ^b   Huang, Yu Tsung ^a   Wang, Hsiu Po ^a   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METRONIDAZOLE; TIGECYCLINE; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; AGAR DILUTION; BLOODY DIARRHEA; CANCER STAGING; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; FECES ANALYSIS; FEMALE; FEVER; FIBERSCOPE ENDOSCOPY; HUMAN; HYPOTENSION; LETTER; LYMPH NODE DISSECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OMENTUM; PERITONEUM METASTASIS; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SALPINGOOOPHORECTOMY; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE;

EID: 73749083797     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.11.008     Document Type: Letter

References (7)

1. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145 (2006) 758-764
2. McDonald L.C., Owings M., and Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 12 (2006) 409-415
3. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47 (2008) 1162-1170
4. Hecht D.W., Galang M.A., Sambol S.P., Osmolski J.R., Johnson S., and Gerding D.N. In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 51 (2007) 2716-2719
5. Bartlett J.G. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Clin Infect Dis 46 (2008) 1489-1492
6. Pépin J., Valiquette L., Gagnon S., Routhier S., and Brazeau I. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 102 (2007) 2781-2788
7. Herpers B.L., Vlaminckx B., Burkhardt O., Blom H., Biemond-Moeniralam H.S., Hornef M., et al. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection. Clin Infect Dis 48 (2009) 1732-1735